Adverse events in Irish hospitals

Adverse events in Irish hospitals Research shows 1 in 8 patients admitted to hospital in 2009 experienced adverse events. This is the first time such research has been carried out in Ireland and the figures are broadly consistent with baseline studies conducted in other countries.  Adverse events are  unintended injuries or complications resulting from healthcare…

Read More

Ireland’s first National Maternity Strategy

Ireland’s first National Maternity Strategy This  aims to improve safety & quality in general and standardise care across all units by recommending “Health and Wellbeing” approach giving babies the best start and improve women’s health by having women’s choices facilitated where possible as well as having better staff levels and facilities in maternity units and…

Read More

More access to reports on adverse reactions on medicines in EU

EMA giving increased access to reports on suspected adverse reactions on medicines authorised in EU The EMA will give increased access to reports on suspected adverse reactions to medicines authorised in the European Union, while guaranteeing that personal data will be fully protected. This results from a revision of Eudra Vigilance Access policy adopted by…

Read More

ILCA 2nd School of Liver Cancer 2016

EVENT 2nd International Liver Cancer Association (ILCA),  Mar 7 – 8, 2016. This will be hosted by the Barcelona Clínic Liver Cancer (BCLC) at the Hospital Clínic of Barcelona on 7–8 March 2016, Barcelona, Spain. Liver Cancer: Future Prospects in Management and Research Scheduled for one and half day to provide presentations about current knowledge…

Read More

ESMO Symposium on Signalling Pathways in Cancer

EVENT ESMO Symposium on Signalling Pathways in Cancer Focus on HER/EGFR family signalling European Society for Medical Oncology (ESMO),   Mar  4 – 5,  Barcelona, Spain 4th Symposium ‘Focusing on HER/EGFR family signalling’ will be held in partnership with EACR. The Symposium is designed for medical oncologists, clinical and industry researchers and young  oncologists.  Bring academics,…

Read More